Syndax Pharmaceuticals, Inc. (SNDX)
24.23
+0.42
(+1.76%)
USD |
NASDAQ |
Apr 17, 16:00
24.20
-0.02
(-0.10%)
Pre-Market: 20:00
Syndax Pharmaceuticals Free Cash Flow : -323.17M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cogent Biosciences, Inc. | -266.00M |
| Vera Therapeutics, Inc. | -241.73M |
| Biogen, Inc. | 1.969B |
| Johnson & Johnson | 19.70B |
| Tango Therapeutics, Inc. | -139.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -69.49M |
| Cash from Investing (Quarterly) | 81.58M |
| Cash from Financing (Quarterly) | 5.917M |
| Free Cash Flow Per Share (Quarterly) | -0.7961 |
| Free Cash Flow to Equity (Quarterly) | -69.54M |
| Free Cash Flow to Firm (Quarterly) | -59.95M |
| Free Cash Flow Yield | -15.40% |